Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Stud... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817641) titled 'Proton Therapy for Mediastinal Lymphoma (PROMLY)' on July 30. Brief Summary: The study ai... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Antigen Targeted T cell therapy for Relapsed/Refractory B cell Lymphomas'. The following are the ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A multicenter open-label extension study to evaluate long-term safety and efficacy of QCZ484 in h... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817342) titled 'Effects of an Exercice Program of 4-w for the Improvement of Functional Ankle Instability ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More